Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon
A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare

TVT 2023: Cardiovascular Research Foundation announces late-breaking clinical trials

In addition to these 15 late-breaking clinical studies, TVT 2023 will feature live cases, hands-on training, poster presentations and much more.

Data on a next-generation balloon-expandable transcatheter heart valve

Next-gen TAVR valve, tested on patients for very first time, linked to high success rate

A new-look TAVR valve was tested on patients for the first time, leading researchers to say its use appears to be "feasible and safe." More research, of course, is still required. 

M&A mergers and acquisitions business deal

Report: Medtronic, Johnson & Johnson consider Shockwave Medical acquisition after Boston Scientific talks stall

Shockwave Medical has already had a busy, successful 2023—what could be next for the IVL specialists?

artificial intelligence AI deep learning

AI model predicts LVEF during routine coronary angiograms

The video-based deep neural network showed potential for limiting invasive exams and improving patient care. 

dollar money graph increase finance

Shockwave Medical announces huge Q1 growth, including skyrocketing revenue, amid Boston Scientific rumors

The company reported a Q1 revenue of $161.1 million, up 72% from Q1 in 2022. Both gross profit and net income were also up considerably when compared to 2022. 

Intravascular lithotripsy (IVL) Shockwave Medical PCI PAD CAD Disrupt PAD Disrupt CAD SCAI 2022

Boston Scientific’s deal to acquire Shockwave Medical reportedly hits a snag

Talks between the two companies have reached a standstill, according to a new report. The rumor appears to have impacted the stock prices of both Boston Scientific and Shockwave Medical. 

James Muller MD discusses vulnerable plaque and nuclear weapons as recipient of ACC Distinguished Scientist award. The right image in the near infrared spectroscopy system he developed to find vulnerable plaques.

Nobel Prize-winning cardiologist on his quest to find and treat vulnerable plaques

Pioneering cardiologist James Muller, MD, a winner of the Nobel Peace Prize, was one of the chief researchers that developed the concept of vulnerable plaques causing heart attacks. He was recently honored by the American College of Cardiology for his contributions.

Thumbnail

How improving access to PCI affects heart attack outcomes

When PCI-capable hospitals open and close, how does it impact patient care for the surrounding area? Researchers aimed to find out, sharing their findings in JACC: Cardiovascular Interventions.

Displaying 401 - 408 of 975
Design by Adaptive Theme